在光热疗法中准与瘤相关的碳酸无水
Sébastien Clément1, Sébastien Richeter1, Jean-Yves Winum2
1ICGM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
ChemMedChem
|January 14, 2025
概括
通过光热疗法 (PTT) 向人类碳酸无水体 (hCA) 显示出癌症治疗的前景. 将hCA抑制与PTT结合起来可以提高治疗效率和精度,从而改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 生物医学工程 生物医学工程
背景情况:
- 与瘤相关的人类碳酸无水酶 (hCA),特别是hCA IX和hCA XII,在缺氧瘤区域过度表达.
- 这些hCA对于pH调节,癌细胞存活和侵入性至关重要,使它们成为有吸引力的治疗点.
- 光热疗法 (PTT) 使用近红外 (NIR) 光和吸光剂产生热量,诱导癌细胞亡.
研究的目的:
- 审查最近在开发用于癌症治疗的hCA向光热剂方面的进展.
- 探索将hCA抑制策略与PTT集成在一起,以改善瘤治疗.
- 突出结合hCA抑制与PTT用于精确有效的癌症治疗的潜力.
主要方法:
- 对针对hCA的光热剂和组合疗法的最新科学文献的审查.
- 专注于与瘤相关的异型hCA IX和hCA XII.
- 分析通过hCA向提高PTT的疗效和特异性的策略.
主要成果:
- 针对hCA的光热剂显示出对选择性癌细胞剥离的潜力.
- 抑制hCA可以提高PTT的疗效和特异性.
- 整合hCA抑制和PTT的组合疗法为癌症治疗提供了一个有前途的方法.
结论:
- 将hCA抑制与PTT结合起来,代表了癌症的创新治疗策略.
- 需要进一步的研究来改善这些药物的生物相容性,稳定性和临床转化.
- 这种方法有望推动更精确,更有效的癌症治疗方法.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
469
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
469
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


